August 2020 Issue

GO TO FULL ISSUE


Need CE? Access a library of 300+ pharmacist CE courses with a subscription to Pharmacist's Letter Canada

MED UPDATES

Spravato
esketamine
An intranasal NMDA antagonist for depression

Rybelsus
semaglutide
New oral formulation GLP-1 agonist for type 2 diabetes

Mayzent
siponimod
An oral sphingosine 1-phosphate receptor modulator for multiple sclerosis

MORE MED UPDATES